Back to search
FDAFDA · Food and drugs·Recall number D-0140-2024

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1

Published December 13, 2023 · Recall initiated: November 9, 2023

Summary

FDA records drug Class III recall D-0140-2024, published December 13, 2023 and initiated November 9, 2023. Recalling firm: Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop; Status: Terminated; Reported quantity: 190 syringes; Lot: Lot#: 09202023@7, Exp 03/18/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product Mix-up: Incorrect Product Formulation

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop
Distributor
USA Nationwide
Lot
Lot#: 09202023@7, Exp 03/18/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1 recalled?

Yes. FDA published recall D-0140-2024 on December 13, 2023. Reported hazard: Product Mix-up: Incorrect Product Formulation

What should I do if I have this product?

Voluntary: Firm initiated